Viewing data from:

GLYCOPYRRONIUM TOSYLATE

ANDA

GLYCOPYRRONIUM TOSYLATE | A214448 | PADAGIS US LLC

1 strength0 unique patents0 unique exclusivities

Hatch-Waxman Litigation

1 case on OB patents from PACER

Case	Court	Filed	Status	Judge
Journey Medical Corporation et al v. Perrigo Pharma International DAC 1:2020cv01413 8 patentsANDA 214448Glycopyrronium	D. Del.	2020-10-21	Terminated 2022-05-19	—

Source: PACER. NOS 835 (Patent - Abbreviated New Drug Application).

API Supply Chain1 active DMF

1 active API supplier hold Drug Master Files for this ingredient. Limited supplier base — potential supply chain risk.

SUVEN PHARMACEUTICALS LTDGLYCOPYRRONIUM TOSYLATE

DMF 336672019

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Products (1)

#001 — EQ 2.4% BASE

0 patents0 exclusivities▴

CLOTH;TOPICAL | Approved: Apr 3, 2026

No patent or exclusivity listings for this strength.